基本分析
透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。
基本資料
個股的基本資料,以及所屬的類股和產業。
公司介紹
業務介紹
卡特蘭特公司及其子公司在全球範圍內開發和製造藥品、蛋白質生物製劑、細胞和基因療法以及消費者健康產品的解決方案。該公司分為四個業務部門:生物製劑、軟膠囊和口服技術、口服和特殊給藥以及臨床供應服務。
軟膠囊和口服技術部門為各種客戶產品(如處方藥、非處方藥、膳食補充劑、單劑量化妝品和動物保健藥物製劑)提供軟膠囊的配方、開發和製造服務。
生物製劑部門提供生物細胞系;開發和製造細胞療法和基於病毒的基因療法;為包括小瓶、預充注射器、小瓶和卡匣在內的非經口劑型提供配方、開發和製造服務;以及分析開發和測試服務。
口服和特殊給藥部門提供涵蓋一系列技術的配方、開發和製造服務,以及集成的下游臨床開發和商業供應解決方案。該部門還提供包括臨床前篩選、配方、分析開發和現行良好製造規範服務的口服給藥解決方案平台。
臨床供應服務部門提供藥品和生物製劑臨床試驗的製造、包裝、儲存、配送和庫存管理。它還提供基於需求的快速臨床供應服務。
該公司為製藥、生物技術和消費者健康公司以及動物保健和醫療器械等其他醫療市場細分領域以及化妝品行業的公司提供服務。卡特蘭特公司於2007年註冊成立,總部位於新澤西州薩默塞特。
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.
警語
1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整,需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。